Video: Angela Osborne Discusses the Latest Cell and Gene Industry Trends
Check out our video interview with Angela Osborne, CEO and founder of eXmoor Pharma, who joined us from the ISCT convention in Paris (2023).
Stephanie Sutton | | Video
With over 30 years’ experience in biopharmaceutical and cell and gene therapy businesses, Angela Osborne shares valuable insight on the latest industry trends, investment strategies in CGT, COVID-19, iPSCs, and more!
Originally a biochemical engineer from UCL, Angela is the CEO and founder of eXmoor pharma, a “trusted one-stop cell and gene therapy partner, accelerating the manufacturing journey from research to patients,” which she founded in 2004.
In the past, Angela was Senior Vice President of Pharmaceuticals at Aker Kvaerner, an engineering multinational, where she grew the turnover to equal the previously dominant chemicals business. Angela started her career at British Biotech, where she built on her PhD, with practical experience of biopharmaceutical process development, scale-up, facility design, validation, and operation of facilities to US and EU GMPs.